CoChat

Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Patient-derived cellular models become an increasingly powerful tool to model human diseases for precision medicine approaches. The identification of robust cellular disease phenotypes in these models paved the way towards high throughput screenings (HTS) including the implementation of laboratory advanced automation. However, maintenance and expansion of cells for HTS remains largely manual work. Here, we describe an integrated, complex automated platform for HTS in a translational research setting also designed for maintenance and expansion of different cell types. The comprehensive design allows automation of all cultivation steps and is flexible for development of methods for variable cell types. We demonstrate protocols for controlled cell seeding, splitting and expansion of human fibroblasts, induced pluripotent stem cells (iPSC), and neural progenitor cells (NPC) that allow for subsequent differentiation into different cell types and image-based multiparametric screening. Furthermore, we provide automated protocols for neuronal differentiation of NPC in 2D culture and 3D midbrain organoids for HTS. The flexibility of this multitask platform makes it an ideal solution for translational research settings involving experiments on different patient-derived cellular models for precision medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-81129-3

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of the automated platform. (1) Liquid handler Biomek NX Span-8 including the plate shaker Shaking Peltier ALP and a tilting station Amplius (AIG) 3D Tilting ALP, (2) Liquid handler Biomek FXP (96- and 384-pipetting head including active wash-station and a BioShake 3000, (3) Acoustic droplet ejector Labcyte Echo550, (4) High content imager Yokogawa CV8000, (5) plate sealer Wasp, (6) Cell counter Vi-Cell XR12, (7) plate seal remover Nexus Xpeel, (8) Barcode printer and reader Scinomix Sci-Print MP2, (9) Precise SCARA robotic arm on rail, (10) 4 °C and 37 °C incubators Cytomat 24-C, (11) Sigma refrigerated centrifuge 6-16KR, (12) Tube de-capper Cap-it All, (13) Plate washer Biotek 405 LSHTV, (14) Multimode plate reader SpectraMax i3 Multi-Mode Platform and Minimax imager, (15) Custom made biosafety class 2 enclosure, (16) 2D-barcode reader Visionmate, (17) 4 deliiding modules, (18) 5 Tipbox labware feeders, (19) Regrip station, (20) 4 shelf labware hotel.
Figure 1 Schematic of the automated platform. (1) Liquid handler Biomek NX Span-8 including the plate shaker Shaking Peltier ALP and a tilting station Amplius (AIG) 3D Tilting ALP, (2) Liquid handler Biomek FXP (96- and 384-pipetting head including active wash-station and a BioShake 3000, (3) Acoustic droplet ejector Labcyte Echo550, (4) High content imager Yokogawa CV8000, (5) plate sealer Wasp, (6) Cell counter Vi-Cell XR12, (7) plate seal remover Nexus Xpeel, (8) Barcode printer and reader Scinomix Sci-Print MP2, (9) Precise SCARA robotic arm on rail, (10) 4 °C and 37 °C incubators Cytomat 24-C, (11) Sigma refrigerated centrifuge 6-16KR, (12) Tube de-capper Cap-it All, (13) Plate washer Biotek 405 LSHTV, (14) Multimode plate reader SpectraMax i3 Multi-Mode Platform and Minimax imager, (15) Custom made biosafety class 2 enclosure, (16) 2D-barcode reader Visionmate, (17) 4 deliiding modules, (18) 5 Tipbox labware feeders, (19) Regrip station, (20) 4 shelf labware hotel.CC BY · PubMed Central
Figure 2 Quality control of cell seeding. (a) Fibroblast images taken with the multimode plate reader to determine confluency without (top) and with (bottom) mask highlighting areas covered by cells. (b) Acquisition mask for confluency measurement of a 1-well plate (top) and a 6-well plate (bottom). Each field represents a field of acquisition and numbers in the fields indicate percentage of confluency. (c–e) Non-linear curve fitting on confluency reads of serially diluted or split fibroblasts (n = 3) (c), smNPC (n = 7) (d), and iPSC (n = 4) (e). (f) Measurement of CV after dispensing test with fibroblast into dry or pre-wetted 6-wells. n = 3. (g) Measurement of CV after testing dispensing speeds with fibroblast in 6-wells. n = 6 (h) Measurement of CV after testing dispensing speeds with iPSC in 6-wells. n = 9, statistical test used: Mann–Whitney test.
Figure 2 Quality control of cell seeding. (a) Fibroblast images taken with the multimode plate reader to determine confluency without (top) and with (bottom) mask highlighting areas covered by cells. (b) Acquisition mask for confluency measurement of a 1-well plate (top) and a 6-well plate (bottom). Each field represents a field of acquisition and numbers in the fields indicate percentage of confluency. (c–e) Non-linear curve fitting on confluency reads of serially diluted or split fibroblasts (n = 3) (c), smNPC (n = 7) (d), and iPSC (n = 4) (e). (f) Measurement of CV after dispensing test with fibroblast into dry or pre-wetted 6-wells. n = 3. (g) Measurement of CV after testing dispensing speeds with fibroblast in 6-wells. n = 6 (h) Measurement of CV after testing dispensing speeds with iPSC in 6-wells. n = 9, statistical test used: Mann–Whitney test.CC BY · PubMed Central
Figure 3 Automated cell cuture maintenance. (a) Confluency of fibroblasts 24 h post seeding in 6-well plates split either manually or with automated methods 1, 2, 3, or 4 into three destination wells. n = 10 statistical test used: one-way ANOVA with addhoc Tukey’s test. (b) CV of fibroblasts 24 h post seeding in 6-well plates split either manually or with automated methods 1, 2, 3, or 4 into three destination wells. After passaging with method 4 plates were either left unshaken (4.1) or shaken for 1 min (4.2) or 5 min (4.3) with a linear shaker, 3 min with an orbital shaker (4.4), or pivoted with the tilting station for 3 min (4.5). n = 10 statistical test used: one-way ANOVA with addhoc Sidak’s test. (c, d) Representative image of iPSC 24 h post splitting with EDTA (c), or dispase (d). (e) Confluency of 20 6-well plates of iPSC 24 h after splitting them either manually or with the automated method 1:7. (f) CV of iPSC from (e) n = 10 statistical test used: Mann–Whitney test. (g) Confluency of 20 6-well plates of smNPC 24 h after splitting them either manually or with the automated method 1:7. (h) CV of smNPC from (f) n = 10 statistical test used: Mann–Whitney test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 3 Automated cell cuture maintenance. (a) Confluency of fibroblasts 24 h post seeding in 6-well plates split either manually or with automated methods 1, 2, 3, or 4 into three destination wells. n = 10 statistical test used: one-way ANOVA with addhoc Tukey’s test. (b) CV of fibroblasts 24 h post seeding in 6-well plates split either manually or with automated methods 1, 2, 3, or 4 into three destination wells. After passaging with method 4 plates were either left unshaken (4.1) or shaken for 1 min (4.2) or 5 min (4.3) with a linear shaker, 3 min with an orbital shaker (4.4), or pivoted with the tilting station for 3 min (4.5). n = 10 statistical test used: one-way ANOVA with addhoc Sidak’s test. (c, d) Representative image of iPSC 24 h post splitting with EDTA (c), or dispase (d). (e) Confluency of 20 6-well plates of iPSC 24 h after splitting them either manually or with the automated method 1:7. (f) CV of iPSC from (e) n = 10 statistical test used: Mann–Whitney test. (g) Confluency of 20 6-well plates of smNPC 24 h after splitting them either manually or with the automated method 1:7. (h) CV of smNPC from (f) n = 10 statistical test used: Mann–Whitney test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Figure 4 Automated cell culture expansion. (a) Confluency of fibroblasts 24 h post splitting for 1st and 2nd expansion step. n = 10, 1st step = Mann–Whitney test; 2nd step = two-tailed t-test. (b) CV of fibroblast plates from (a). two-tailed t-test. (c) Confluency of iPSC 24 h post splitting for 1st (n = 12) and 2nd (n = 10) expansion step. 1st step = two-tailed t-test; 2nd step = Mann–Whitney test. (d) CV of iPSC plates from (c). 1st step = Mann–Whitney test, 2nd step = two-tailed t-test. (e) Confluency of smNPC 24 h post splitting for 1st and 2nd expansion step . n = 10, two-tailed t-test. (f) CV of smNPC plates from (e). n = 10, 1st step = Mann–Whitney test; 2nd step = two-tailed t-test. (g) Number of cells counted from confluent 1-well plates. n = 8. *p < 0.05, **p < 0.01, ****p < 0.0001.
Figure 4 Automated cell culture expansion. (a) Confluency of fibroblasts 24 h post splitting for 1st and 2nd expansion step. n = 10, 1st step = Mann–Whitney test; 2nd step = two-tailed t-test. (b) CV of fibroblast plates from (a). two-tailed t-test. (c) Confluency of iPSC 24 h post splitting for 1st (n = 12) and 2nd (n = 10) expansion step. 1st step = two-tailed t-test; 2nd step = Mann–Whitney test. (d) CV of iPSC plates from (c). 1st step = Mann–Whitney test, 2nd step = two-tailed t-test. (e) Confluency of smNPC 24 h post splitting for 1st and 2nd expansion step . n = 10, two-tailed t-test. (f) CV of smNPC plates from (e). n = 10, 1st step = Mann–Whitney test; 2nd step = two-tailed t-test. (g) Number of cells counted from confluent 1-well plates. n = 8. *p < 0.05, **p < 0.01, ****p < 0.0001.CC BY · PubMed Central
Figure 5 Automated neural differentiation in 2D and 3D. (a) Representative image of neurons produced with an automated 2D differentiation protocol for midbrain dopaminergic neurons. Cells were stained with HOECHST (blue, nuclei), anti-Tuj1 antibodies (green, pan-neuronal marker), and anti-tyrosine hydroxylase (TH) antibody (red, dopaminergic neurons). Scale bar = 200 µm. (b) Exemplary flowcytometric analysis of Tuj1 and TH expression in neurons from the same differentiation as in (a). (c) Bright field images of organoids from the same differentiation at indicated days of generation. Scale bar = 500 µm. (d–g) Analysis of organoid sizes extracted from brightfield microscopy images. Experiments between which the measured parameter was not significantly different are marked (ns). The observed differences between all other experiments were statistically significant (p < 0.05). (d) Organoid area at the end of differentiation (day 30). Five independent differentiations each with 96 organoids are shown. Differentiations were performed at different times. Kruskal–Wallis test followed by Dunn’s multiple comparison test. (e) Feret’s diameter of the organoids from (d). Kruskal–Wallis test followed by Dunn´s multiple comparison test. (f) Organoid area at the end of differentiation from a replication experiment. Differentiations were performed simultaneously. Kruskal–Wallis test followed by Dunn’s multiple comparison test. (g) Feret’s diameter of the organoids from (f). Kruskal–Wallis test followed by Dunn’s multiple comparison test. (h) Representative immunofluorescence images (maximum intensity projection) of organoids from (d) stained with HOECHST (blue, nuclei), anti-Map2 antibodies (white, pan-neuronal marker), and anti-tyrosine hydroxylase (TH) antibody (red, dopaminergic neurons). Scale bar = 50 µm.
Figure 5 Automated neural differentiation in 2D and 3D. (a) Representative image of neurons produced with an automated 2D differentiation protocol for midbrain dopaminergic neurons. Cells were stained with HOECHST (blue, nuclei), anti-Tuj1 antibodies (green, pan-neuronal marker), and anti-tyrosine hydroxylase (TH) antibody (red, dopaminergic neurons). Scale bar = 200 µm. (b) Exemplary flowcytometric analysis of Tuj1 and TH expression in neurons from the same differentiation as in (a). (c) Bright field images of organoids from the same differentiation at indicated days of generation. Scale bar = 500 µm. (d–g) Analysis of organoid sizes extracted from brightfield microscopy images. Experiments between which the measured parameter was not significantly different are marked (ns). The observed differences between all other experiments were statistically significant (p < 0.05). (d) Organoid area at the end of differentiation (day 30). Five independent differentiations each with 96 organoids are shown. Differentiations were performed at different times. Kruskal–Wallis test followed by Dunn’s multiple comparison test. (e) Feret’s diameter of the organoids from (d). Kruskal–Wallis test followed by Dunn´s multiple comparison test. (f) Organoid area at the end of differentiation from a replication experiment. Differentiations were performed simultaneously. Kruskal–Wallis test followed by Dunn’s multiple comparison test. (g) Feret’s diameter of the organoids from (f). Kruskal–Wallis test followed by Dunn’s multiple comparison test. (h) Representative immunofluorescence images (maximum intensity projection) of organoids from (d) stained with HOECHST (blue, nuclei), anti-Map2 antibodies (white, pan-neuronal marker), and anti-tyrosine hydroxylase (TH) antibody (red, dopaminergic neurons). Scale bar = 50 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 43

Metadata

Authors
Boussaad, I., Cruciani, G., Bolognin, S., Antony, P., Dording, C. M., Kwon, Y.-J., Heutink, P., Fava, E., Schwamborn, J. C., & Krüger, R.
Affiliations
  • University of Luxembourg (LU)
  • German Center for Neurodegenerative Diseases (DE)
  • Centre Hospitalier de Luxembourg (LU)
Corresponding author
Krüger, Rejko
Venue
Scientific Reports
Published
2021-01-14
Volume
11
Issue
1
Pages
1439-1439
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3120413946
Cited by
42
References
45
Citations by year
2026: 9 · 2025: 8 · 2024: 5 · 2023: 9 · 2022: 5 · 2021: 6
FWCI
1.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
  • DZNE Pub (submittedVersion, cc-by)
Funders
  • Fonds National de la Recherche Luxembourg (FNR/P13/6682797, INTER/JPND/15/11092422)
  • EU Joint Programme – Neurodegenerative Disease Research (INTER/JPND/15/11092422)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
Keywords
high-throughput drug screening, automated cell culture, induced pluripotent stem cells, neural progenitor cells, human fibroblasts, neuronal differentiation, midbrain organoids, 3D organoids, precision medicine, translational research
MeSH terms
Drug Evaluation, Preclinical, Humans, Models, Biological, Organoids, Cell Culture Techniques, Automation, Laboratory, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening. https://app.cochat.ai/papers/10.1038/s41598-021-81129-3
The paper
Boussaad, I., Cruciani, G., Bolognin, S., Antony, P., Dording, C. M., Kwon, Y.-J., Heutink, P., Fava, E., Schwamborn, J. C., & Krüger, R. (2021). Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening. Scientific Reports. https://doi.org/10.1038/s41598-021-81129-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.